Acetate
- Generic Name
- Acetate
- Drug Type
- Small Molecule
- Chemical Formula
- C2H3O2
- CAS Number
- 71-50-1
- Unique Ingredient Identifier
- 569DQM74SC
Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation
Phase 2
Completed
- Conditions
- Constipation
- First Posted Date
- 2006-03-24
- Last Posted Date
- 2009-03-24
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00306748
- Locations
- ๐บ๐ธ
Arkansas Gastroenterology, North Little Rock, Arkansas, United States
๐บ๐ธMemphis Gastroenterology Clinic, Germantown, Tennessee, United States
๐บ๐ธConsultants for Clinical Research of South Florida, Boynton Beach, Florida, United States
Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS
Phase 2
Completed
- Conditions
- Irritable Bowel Syndrome
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2006-10-20
- Lead Sponsor
- Ironwood Pharmaceuticals, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT00258193
- Locations
- ๐บ๐ธ
Mayo Clinic Foundation, Rochester, Minnesota, United States
A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients
Phase 2
Completed
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2016-07-22
- Lead Sponsor
- Duramed Research
- Target Recruit Count
- 315
- Registration Number
- NCT00196339
- Locations
- ๐จ๐ฆ
Duramed Investigational Site, Pointe-Claire, Quebec, Canada
๐บ๐ธDuramed Investiational Site, Ocala, Florida, United States
๐บ๐ธDuramed Investigational site, Garden City, New York, United States
Hormonal Contraception and Risk of Chlamydia and Gonorrhea
Terminated
- Conditions
- Chlamydia InfectionNeisseriaceae Infection
- First Posted Date
- 2004-09-20
- Last Posted Date
- 2005-11-07
- Lead Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Target Recruit Count
- 1200
- Registration Number
- NCT00091728
S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer
Phase 3
Completed
- Conditions
- Breast CancerHot Flashes
- Interventions
- First Posted Date
- 2004-06-28
- Last Posted Date
- 2015-11-18
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 288
- Registration Number
- NCT00005975
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath